HANDOK Inc. (KRX:002390)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,860
-30 (-0.25%)
At close: Dec 5, 2025
-4.82%
Market Cap 154.07B
Revenue (ttm) 516.37B
Net Income (ttm) -43.54B
Shares Out 12.99M
EPS (ttm) -3,162.37
PE Ratio n/a
Forward PE n/a
Dividend 200.00 (1.68%)
Ex-Dividend Date Feb 27, 2025
Volume 4,270
Average Volume 12,017
Open 11,900
Previous Close 11,890
Day's Range 11,800 - 11,920
52-Week Range 10,500 - 14,250
Beta 0.42
RSI 57.45
Earnings Date Nov 12, 2025

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides ETC and OTC drugs; and medical devices and research products, including blood pressure monitors, cholesterol monitoring systems, insulin pumps, self monitoring system of blood glucose, and blood glucose monitoring system. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS, orphan diseases, eye disorders, and other disease areas. The company also offers healthcare products comprising food supplements under the NatureSet brand; foo... [Read more]

Sector Healthcare
Founded 1954
Employees 940
Stock Exchange Korea Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2024, HANDOK's revenue was 507.36 billion, a decrease of -2.94% compared to the previous year's 522.74 billion. Losses were -52.56 billion, 82.5% more than in 2023.

Financial Statements

News

There is no news available yet.